1. A phase I trial investigating the Aurora B kinase inhibitor BI 811283 in combination with cytarabine in patients with acute myeloid leukaemia. (19th November 2018) Authors: Döhner, Hartmut; Müller‐Tidow, Carsten; Lübbert, Michael; Fiedler, Walter; Krämer, Alwin; Westermann, Jörg; Bug, Gesine; Schlenk, Richard F.; Krug, Utz; Goeldner, Rainer‐Georg; Hilbert, James; Taube, Tillmann; Ottmann, Oliver G. Journal: British journal of haematology Issue: Volume 185:Number 3(2019) Page Start: 583 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. A randomized, open‐label, phase I/II trial to investigate the maximum tolerated dose of the Polo‐like kinase inhibitor BI 2536 in elderly patients with refractory/relapsed acute myeloid leukaemia. (16th August 2013) Authors: Müller‐Tidow, Carsten; Bug, Gesine; Lübbert, Michael; Krämer, Alwin; Krauter, Jürgen; Valent, Peter; Nachbaur, David; Berdel, Wolfgang E.; Ottmann, Oliver G.; Fritsch, Holger; Munzert, Gerd; Garin‐Chesa, Pilar; Fleischer, Frank; Taube, Tillmann; Döhner, Hartmut Journal: British journal of haematology Issue: Volume 163:Number 2(2013:Oct.) Page Start: 214 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. B‐cell maturation antigen‐specific chimeric antigen receptor T cells for multiple myeloma: Clinical experience and future perspectives. Issue 8 (30th April 2020) Authors: Sellner, Leopold; Fan, Fuli; Giesen, Nicola; Schubert, Maria‐Luisa; Goldschmidt, Hartmut; Müller‐Tidow, Carsten; Dreger, Peter; Raab, Marc S.; Schmitt, Michael Journal: International journal of cancer Issue: Volume 147:Issue 8(2020) Page Start: 2029 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. CD33‐directed immunotherapy with third‐generation chimeric antigen receptor T cells and gemtuzumab ozogamicin in intact and CD33‐edited acute myeloid leukemia and hematopoietic stem and progenitor cells. Issue 7 (23rd November 2021) Authors: Liu, Yi; Wang, Sanmei; Schubert, Maria‐Luisa; Lauk, Annika; Yao, Hao; Blank, Maximilian Felix; Cui, Chunhong; Janssen, Maike; Schmidt, Christina; Göllner, Stefanie; Kleist, Christian; Zhou, Fengbiao; Rahfeld, Jens‐Ulrich; Sauer, Tim; Schmitt, Michael; Müller‐Tidow, Carsten Journal: International journal of cancer Issue: Volume 150:Issue 7(2022) Page Start: 1141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. CD7 is expressed on a subset of normal CD34‐positive myeloid precursors. (4th July 2018) Authors: Kriegsmann, Katharina; Löffler, Harald; Eckstein, Volker; Schulz, Renate; Kräker, Sandra; Braun, Ute; Luft, Thomas; Hegenbart, Ute; Schönland, Stefan; Dreger, Peter; Krämer, Alwin; Ho, Anthony D.; Müller‐Tidow, Carsten; Hundemer, Michael Journal: European journal of haematology Issue: Volume 101:Number 3(2018) Page Start: 318 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. CDK7/12/13 inhibition targets an oscillating leukemia stem cell network and synergizes with venetoclax in acute myeloid leukemia. Issue 4 (7th March 2022) Authors: He, Lixiazi; Arnold, Christian; Thoma, Judith; Rohde, Christian; Kholmatov, Maksim; Garg, Swati; Hsiao, Cheng‐Chih; Viol, Linda; Zhang, Kaiqing; Sun, Rui; Schmidt, Christina; Janssen, Maike; MacRae, Tara; Huber, Karin; Thiede, Christian; Hébert, Josée; Sauvageau, Guy; Spratte, Julia; Fluhr, Herbe... Journal: EMBO molecular medicine Issue: Volume 14:Issue 4(2022) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Characteristics and outcome of patients with acute myeloid leukaemia and t(8;16)(p11;p13): results from an International Collaborative Study. (2nd February 2021) Authors: Kayser, Sabine; Hills, Robert K.; Langova, Ralitsa; Kramer, Michael; Guijarro, Francesca; Sustkova, Zuzana; Estey, Elihu H.; Shaw, Carole M.; Ráčil, Zdeněk; Mayer, Jiri; Zak, Pavel; Baer, Maria R.; Brunner, Andrew M.; Szotkowski, Tomas; Cetkovsky, Petr; Grimwade, David; Walter, Roland B.; Burnett... Journal: British journal of haematology Issue: Volume 192:Number 5(2021) Page Start: 832 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Chimeric antigen receptor transduced T cells: Tuning up for the next generation. Issue 9 (27th November 2017) Authors: Schubert, Maria‐Luisa; Hoffmann, Jean‐Marc; Dreger, Peter; Müller‐Tidow, Carsten; Schmitt, Michael Journal: International journal of cancer Issue: Volume 142:Issue 9(2018) Page Start: 1738 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Clinical impact of KMT2C and SPRY4 expression levels in intensively treated younger adult acute myeloid leukemia patients. (13th October 2017) Authors: Kayser, Sabine; Feszler, Maximilian; Krzykalla, Julia; Schick, Matthias; Kramer, Michael; Benner, Axel; Thol, Felicitas; Platzbecker, Uwe; Müller‐Tidow, Carsten; Ho, Anthony D.; Ehninger, Gerhard; Heuser, Michael; Schlenk, Richard F.; Thiede, Christian; Röllig, Christoph; Krämer, Alwin Journal: European journal of haematology Issue: Volume 99:Number 6(2017) Page Start: 544 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Comments on "Cost of decentralized CAR T cell production in an academic non‐profit setting". Issue 2 (4th September 2020) Authors: Schmitt, Michael; Schmitt, Anita; Thalheimer, Markus; Dreger, Peter; Müller‐Tidow, Carsten Journal: International journal of cancer Issue: Volume 148:Issue 2(2021) Page Start: 514 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗